Tandem Diabetes Care Current Cash

The latest current cash for TNDM is $63M as of June 2026. That compares with $64M in the prior-year period — down 2.0% year over year. Investors often review this figure alongside Tandem Diabetes Care's historical trend and sector peers before judging valuation or financial health.

Over the past year, TNDM's current cash moved from $64M to $63M — a 2.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Tandem Diabetes Care's operating scale or balance-sheet position.

A current cash figure of $63M for TNDM is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting TNDM's current cash ($63M), review year-over-year change from $64M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Tandem Diabetes Care's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.